{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T08:55:35Z","timestamp":1788080135057,"version":"build-2784847793"},"reference-count":53,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"US Food and Drug Administration","doi-asserted-by":"publisher","award":["75F40119C10097"],"award-info":[{"award-number":["75F40119C10097"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jpain.2024.01.350","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T17:32:28Z","timestamp":1706895148000},"page":"104485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Patient Perspectives on Mental Health and Pain Management Support Needed Versus Received During Opioid Deprescribing"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0828-3247","authenticated-orcid":false,"given":"Bobbi Jo H.","family":"Yarborough","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott P.","family":"Stumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Ahmedani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihe G.","family":"Daida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Hooker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwen T.","family":"Lapham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1660-6301","authenticated-orcid":false,"given":"Sonya","family":"Negriff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Rossom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2024.01.350_bib1","unstructured":"Centers for Disease Control and Prevention: Drug Overdose Deaths. Accessed February 28, 2022. https:\/\/www.cdc.gov\/drugoverdose\/deaths\/index.html."},{"key":"10.1016\/j.jpain.2024.01.350_bib2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/15563650.2020.1781150","article-title":"Adult opioid poisonings by drug, intent, and resource use from the United States National Poison Data System from 2005-2018","volume":"59","author":"Land","year":"2021","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.jpain.2024.01.350_bib3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and opioid-involved overdose deaths\u2014United States, 2017-2018","volume":"69","author":"Wilson","year":"2020","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jpain.2024.01.350_bib4","first-page":"1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jpain.2024.01.350_bib5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5055\/jom.2022.0704","article-title":"Impact of state legislation in Tennessee on opioid prescribing practices of orthopedic surgeons","volume":"18","author":"Guidry","year":"2022","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.jpain.2024.01.350_bib6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.7326\/M21-4363","article-title":"Effects of state opioid prescribing laws on use of opioid and other pain treatments among commercially insured U.S. adults","volume":"175","author":"McGinty","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpain.2024.01.350_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention's 2016 Opioid Guideline","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpain.2024.01.350_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2017.8913","article-title":"New data on opioid use and prescribing in the United States","volume":"318","author":"Schuchat","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2024.01.350_bib9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: changes in opioid prescribing in the United States, 2006-2015","volume":"66","author":"Guy","year":"2017","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jpain.2024.01.350_bib10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s11606-020-06252-9","article-title":"Opioid discontinuation among patients receiving high-dose long-term opioid therapy in the veterans health administration","volume":"35","author":"Minegishi","year":"2020","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.jpain.2024.01.350_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109392","article-title":"Dose tapering, increases, and discontinuity among patients on long-term high-dose opioid therapy in the United States, 2017-2019","volume":"234","author":"Nataraj","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpain.2024.01.350_bib12","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s11606-021-07119-3","article-title":"Rapid discontinuation of chronic, high-dose opioid treatment for pain: prevalence and associated factors","volume":"37","author":"Stein","year":"2022","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jpain.2024.01.350_bib13","first-page":"1","article-title":"Drug overdose deaths in the United States, 2001-2021","author":"Spencer","year":"2022","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.jpain.2024.01.350_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103888","article-title":"U.S. state policies on opioid prescribing during the peak of the prescription opioid crisis: associations with opioid overdose mortality","volume":"110","author":"Buonora","year":"2022","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jpain.2024.01.350_bib15","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMp1904190","article-title":"No shortcuts to safer opioid prescribing","volume":"380","author":"Dowell","year":"2019","journal-title":"NEJM"},{"key":"10.1016\/j.jpain.2024.01.350_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsat.2019.05.010","article-title":"Outcomes after opioid dose reductions and stoppage: it's time to start counting","volume":"103","author":"Kertesz","year":"2019","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.jpain.2024.01.350_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/add.14394","article-title":"A crisis of opioids and the limits of prescription control: United States","volume":"114","author":"Kertesz","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.jpain.2024.01.350_bib18","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s11606-020-06253-8","article-title":"Benefits and harms of long-term opioid dose reduction or discontinuation in patients with chronic pain: a rapid review","volume":"35","author":"Mackey","year":"2020","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jpain.2024.01.350_bib19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/08897077.2017.1381663","article-title":"The conundrum of opioid tapering in long-term opioid therapy for chronic pain: a commentary","volume":"39","author":"Manhapra","year":"2018","journal-title":"Subst Abus"},{"key":"10.1016\/j.jpain.2024.01.350_bib20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jama.2021.11013","article-title":"Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids","volume":"326","author":"Agnoli","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2024.01.350_bib21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2022.0323","article-title":"Errors in data analysis and outcomes coding in study of dose tapering and overdose or mental health crisis in patients prescribed opioids","volume":"327","author":"Fenton","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2024.01.350_bib22","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.16726","article-title":"Long-term risk of overdose or mental health crisis after opioid dose tapering","volume":"5","author":"Fenton","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jpain.2024.01.350_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/j.pain.0000000000002298","article-title":"Patient outcomes after opioid dose reduction among patients with chronic opioid therapy","volume":"163","author":"Hallvik","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2024.01.350_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.26523","article-title":"Comparative effectiveness of opioid tapering or abrupt discontinuation vs no dosage change for opioid overdose or suicide for patients receiving stable long-term opioid therapy","volume":"5","author":"Larochelle","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jpain.2024.01.350_bib25","article-title":"Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation","volume":"368","author":"Oliva","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jpain.2024.01.350_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/bmjqs-2021-014186","article-title":"Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the theoretical domains framework","volume":"31","author":"Cross","year":"2022","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.jpain.2024.01.350_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108664","article-title":"\"I felt like I had a scarlet letter\": Recurring experiences of structural stigma surrounding opioid tapers among patients with chronic, non-cancer pain","volume":"222","author":"Benintendi","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpain.2024.01.350_bib28","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1007\/s11606-021-07210-9","article-title":"Patient perspectives on improving patient-provider relationships and provider communication during opioid tapering","volume":"37","author":"Kosakowski","year":"2022","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jpain.2024.01.350_bib29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.japh.2020.12.019","article-title":"Factors associated with opioid-tapering success: a mixed methods study","volume":"61","author":"Kuntz","year":"2021","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.jpain.2024.01.350_bib30","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1097\/j.pain.0000000000002270","article-title":"\"The lesser of two evils\": a framework analysis of consumers' perspectives on opioid deprescribing and the development of opioid deprescribing guidelines","volume":"162","author":"Langford","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2024.01.350_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.japh.2022.05.019","article-title":"\"I really had somebody in my corner.\" patient experiences with a pharmacist-led opioid tapering program","volume":"63","author":"Schneider","year":"2023","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.jpain.2024.01.350_bib32","article-title":"An analysis of primary care clinician communication about risk, benefits, and goals related to chronic opioid therapy","volume":"4","author":"Danielson","year":"2019","journal-title":"MDM Policy Pract"},{"key":"10.1016\/j.jpain.2024.01.350_bib33","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","article-title":"Purposeful sampling for qualitative data collection and analysis in mixed method implementation research","volume":"42","author":"Palinkas","year":"2015","journal-title":"Adm Policy Ment Health"},{"key":"10.1016\/j.jpain.2024.01.350_bib34","article-title":"Impact of opioid dose reductions on patient-reported mental health and suicide-related behavior and relationship to patient choice in tapering decisions","author":"Yarborough","year":"2023","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2024.01.350_bib35","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpain.2024.01.350_bib36","series-title":"APA Handbook of Research Methods in Psychology","first-page":"57","article-title":"Thematic analysis","author":"Braun","year":"2012"},{"key":"10.1016\/j.jpain.2024.01.350_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/17439760.2016.1262613","article-title":"Thematic analysis","volume":"12","author":"Clarke","year":"2017","journal-title":"J Posit Psychol"},{"key":"10.1016\/j.jpain.2024.01.350_bib38","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/nhs.12048","article-title":"Content analysis and thematic analysis: implications for conducting a qualitative descriptive study","volume":"15","author":"Vaismoradi","year":"2013","journal-title":"Nurs Health Sci"},{"key":"10.1016\/j.jpain.2024.01.350_bib39","unstructured":"U. S. Department of Health & Human Services: HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics. Accessed January 12, 2020. https:\/\/www.hhs.gov\/opioids\/sites\/default\/files\/2019-10\/Dosage_Reduction_Discontinuation.pdf."},{"key":"10.1016\/j.jpain.2024.01.350_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpain.2017.06.008","article-title":"I'm Not Gonna Pull the Rug out From Under You\": patient-provider communication about opioid tapering","author":"Matthias","year":"2017","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2024.01.350_bib41","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/j.pain.0000000000002336","article-title":"A qualitative trajectory analysis of patients' experiences tapering opioids for chronic pain","volume":"163","author":"McNeilage","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2024.01.350_bib42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jpain.2018.09.001","article-title":"Patients' experience with opioid tapering: a conceptual model with recommendations for clinicians","volume":"20","author":"Henry","year":"2019","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2024.01.350_bib43","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/pm\/pny228","article-title":"International stakeholder community of pain experts and leaders call for an urgent action on forced opioid tapering","volume":"20","author":"Darnall","year":"2019","journal-title":"Pain Med"},{"key":"10.1016\/j.jpain.2024.01.350_bib44","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s11606-020-06254-7","article-title":"Promoting patient-centeredness in opioid deprescribing: a blueprint for de-implementation science","volume":"35","author":"Kertesz","year":"2020","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jpain.2024.01.350_bib45","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/j.pain.0000000000001763","article-title":"Reducing the use of opioids by patients with chronic pain: an effectiveness study with long-term follow-up","volume":"161","author":"Nicholas","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2024.01.350_bib46","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s11606-022-07880-z","article-title":"Patient and provider perspectives on benefits and harms of continuing, tapering, and discontinuing long-term opioid therapy","volume":"38","author":"Nevedal","year":"2023","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jpain.2024.01.350_bib47","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1503\/cmaj.109-5553","article-title":"\"Complainers, malingerers and drug-seekers\"\u2014the stigma of living with chronic pain","volume":"190","author":"Collier","year":"2018","journal-title":"CMAJ"},{"key":"10.1016\/j.jpain.2024.01.350_bib48","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.socscimed.2017.05.043","article-title":"Opioid pharmacovigilance: a clinical-social history of the changes in opioid prescribing for patients with co-occurring chronic non-cancer pain and substance use","volume":"186","author":"Knight","year":"2017","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.jpain.2024.01.350_bib49","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1037\/adb0000830","article-title":"Opioid use-related stigma and health care decision-making","volume":"37","author":"Brown","year":"2023","journal-title":"Psychol Addict Behav"},{"key":"10.1016\/j.jpain.2024.01.350_bib50","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1370\/afm.2920","article-title":"Impact of stigma on clinician training for opioid use disorder care: a qualitative study in a primary care learning collaborative","volume":"21","author":"Klusaritz","year":"2023","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.jpain.2024.01.350_bib51","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jamapsychiatry.2021.4284","article-title":"Setting limits with controlled substances\u2014the role of motivational interviewing to increase comfort","volume":"79","author":"Marcovitz","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpain.2024.01.350_bib52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5055\/jom.2019.0495","article-title":"Discussions between patients with chronic pain and their primary care provider about opioids and pain relief during routine clinic encounters","volume":"15","author":"Massey","year":"2019","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.jpain.2024.01.350_bib53","first-page":"584","article-title":"Tapering opioids using motivational interviewing","volume":"64","author":"Crawley","year":"2018","journal-title":"Can Fam Physician"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590024003675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590024003675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:04:41Z","timestamp":1751371481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590024003675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1526590024003675"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2024.01.350","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient Perspectives on Mental Health and Pain Management Support Needed Versus Received During Opioid Deprescribing","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2024.01.350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 \u00a9 Published by Elsevier Inc. on behalf of United States Association for the Study of Pain, Inc","name":"copyright","label":"Copyright"}],"article-number":"104485"}}